Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer
Yong Wu, Siyu Chen, Yang Shao, et al.
Advanced Science (2023) Vol. 10, Iss. 31
Open Access | Times Cited: 21

Showing 21 citing articles:

Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Overexpression of miR-124 enhances the therapeutic benefit of TMZ treatment in the orthotopic GBM mice model by inhibition of DNA damage repair
Yuchen Wei, Peng Wang, Jianhui Zhao, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
The miR-1305/KLF5 negative regulatory loop affects pancreatic cancer cell proliferation and apoptosis
Yufu Zhou, Yulin Tang, Feizhou Huang, et al.
Human Cell (2025) Vol. 38, Iss. 2
Closed Access
Porphyromonas gingivalis potentiates stem-like properties of oral squamous cell carcinoma by modulating SCD1-dependent lipid synthesis via NOD1/KLF5 axis
Wenli Zang, Fengxue Geng, Junchao Liu, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Jinshou Yang, Feihan Zhou, Xiyuan Luo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine
Cheng Wang, Xiaoran Han, Shaoqiu Kong, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117955-117955
Closed Access
Irradiation of 125I seeds blocks glycolysis in pancreatic cancer by inhibiting KLF5 m6A methylation through the suppression of RBM15
Jianjun Song, Fuping Kang, Xiaoyan Chang, et al.
Experimental Cell Research (2025), pp. 114538-114538
Closed Access
Cancer chemoprevention: signaling pathways and strategic approaches
Junling Ren, Guangli Yan, Le Yang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Role of KLF5 in enhancing ovarian cancer stemness and PARPi resistance: mechanisms and therapeutic targeting
Huimin Xiao, Guiyun Cheng, Haocheng Zhang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
MiR‐375 impairs breast cancer cell stemness by targeting the KLF5/G6PD signaling axis
Haitao Chen, Shanshan Hou, Hongwei Zhang, et al.
Environmental Toxicology (2024)
Closed Access | Times Cited: 3
Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer
Zhiyuan Yao, Peng Song, Wenjie Jiao
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
KLF5 regulates actin remodeling to enhance the metastasis of nasopharyngeal carcinoma
Zhenyu Yang, Yanfu Peng, Yaqin Wang, et al.
Oncogene (2024) Vol. 43, Iss. 23, pp. 1779-1795
Open Access | Times Cited: 2
Leveraging PARP-1/2 to Target Distant Metastasis
Mallory I. Frederick, Djihane Abdesselam, Anna Clouvel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9032-9032
Open Access | Times Cited: 2
Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression
Xinrong Li, Zhixiang Hu, Qili Shi, et al.
Oncogene (2024)
Closed Access | Times Cited: 2
NEDD4L affects KLF5 stability through ubiquitination to control ferroptosis and radiotherapy resistance in oesophageal squamous cell carcinoma
Jinjin Chen, Kaijun Ying, Jian Sun, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 18
Open Access | Times Cited: 2
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer
Rui Bi, Li Chen, Mei Huang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189221-189221
Open Access | Times Cited: 2
Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma
Jiayu Lin, Pengyi Liu, Keyan Sun, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Characteristics of PD‐1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients
Yanjuan Chen, Yong Chen, Ping Chen, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 10
Open Access
Suppression of KLF5 targets RREB1 to restrain the proliferation of ovarian cancer cells through ERK/MAPK signaling pathway
Shenglan Wang, Chuanchuan Liu, Yongchuan Li, et al.
3 Biotech (2024) Vol. 15, Iss. 1
Closed Access
KLF5 silencing restrains proliferation, invasion, migration and angiogenesis of gallbladder carcinoma cells by transcriptional regulation of PDGFA
Xiaowei Lu, Kui Hu, Dandan Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 151, Iss. 1
Open Access
Page 1

Scroll to top